The European Commission has approved an investment package of more than €280 million from the EU budget for over 120 new LIFE programme projects. This EU funding will trigger total investments of nearly €590 million to help meet these projects’ ambitious goals for environment, nature, and climate action. This amount represents a 37% rise compared to last year.
The projects will help to achieve the European Green Deal objectives by supporting the EU Biodiversity Strategy and the Circular Economy Action Plan, contributing to the green recovery from the Coronavirus pandemic, and helping Europe become a climate-neutral continent by 2050, among others. Many of the new projects are cross-country projects involving several Member States.
Frans Timmermans, Executive Vice-President for the European Green Deal said: “The European Green Deal is our roadmap to a green, inclusive, and resilient Europe. LIFE projects epitomise these values as they bring together Member States for the protection of our environment, the restoration of nature, and support of biodiversity. I’m looking forward to the results of these new projects.”
Virginijus Sinkevičius, Commissioner for the Environment, Oceans and Fisheries added: “LIFE projects can really make a tangible difference on the ground. They bring solutions to some of the most serious challenges of our time such as climate change, loss of nature and unsustainable use of resources. If replicated across the EU at speed and scale, they can help the EU achieve its ambitious EU Green Deal goals and contribute to building a greener and more resilient Europe for all of us, but also for generations to come.”
Approximately €220 million are allocated to a wide range of projects on environment and resource efficiency, nature and biodiversity, and environmental governance and information and over €60 million to support climate change mitigation, adaptation and governance and information projects.
This includes major investments aimed at protecting and enhancing Europe’s biodiversity. Projects such as restoring peatlands – unique ecosystems home to many highly adapted, rare and threatened species – will contribute to the implementation of the EU Biodiversity Strategy. Peatlands are also an important carbon sink, and can boost Europe’s drive toward climate neutrality by 2050.
The LIFE projects also support reducing energy consumption in new buildings, in line with the recently launched EU Renovation Wave Strategy. Funds will go into developing universal and affordable low-carbon solution that could reduce energy consumption in all new buildings by up to 40%.
Funds will also go towards projects that prevent food waste and lead to improved waste management in line with the new EU’s Circular Economy Action Plan.
Financial resources are also being earmarked for numerous projects that will help energy-intensive industries to reduce greenhouse gas emissions in line with the Commission’s ambitious Climate Target Plan and our climate neutrality objective.
The numbers in brief
- 34 LIFE nature & biodiversity projects will support the implementation of the EU Birds and Habitats Directives as well as the EU Biodiversity Strategy to 2030. They have a total budget of €221 million, of which the EU will pay €133 million.
- 47 LIFE environment and resource efficiency projects will mobilise €208 million, of which the EU will provide €76 million. These projects cover actions in five areas: air, environment and health, resource efficiency and circular economy, waste, and water.
- 8 LIFE environmental governance and information projects of nearly €17 million with just over €9 million EU contribution will raise awareness of environmental issues among the wider public and help public authorities to promote, monitor and enforce compliance with EU environmental legislation.
- 16 LIFE climate change mitigation projects will have a total budget of approximately €86 million, of which just under €32 million from the EU.
- 15 LIFE climate change adaptation projects will mobilise €50 million, €26 million of which will come from EU funds.
- 3 LIFE climate governance and information projects will improve governance and raise awareness about climate change with a total budget of €7 million of which the EU is contributing just under €4 million.
Project descriptions and more details can be found in the Annex to this press release.
The projects were selected among more than 1250 applications submitted under the LIFE 2019 call for proposals, published in April 2019. The LIFE programme is the EU’s funding instrument for the environment and climate action. It has been running since 1992 and has co-financed more than 5 500 projects across the EU and in third countries. At any given moment, some 1 100 projects are in progress. The budget for 2014–2020 is set at €3.4 billion in current prices. For the next long-term EU budget 2021-2027, the Commission is proposing to increase LIFE funding by almost 60%.
Coronavirus: EU Strategy for the development and availability of therapeutics
The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Today’s Strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.
It is part of the strong European Health Union, in which all EU countries prepare and respond together to health crises and ensure the availability of affordable and innovative medical supplies – including the therapeutics needed to treat COVID-19.
The Strategy includes clear actions and targets, including authorising three new therapeutics to treat COVID-19 by October 2021 and possibly two more by end of the year. Concretely:
- Research, development and innovation
- Invest €90 million in population studies and clinical trials to establish links between risk factors and health outcomes to further inform public health policy and clinical management, including for long-COVID patients.
- Set up a ‘therapeutics innovation booster’ by July 2021 to support the most promising therapeutics from preclinical research to market authorisation. It will build on current initiatives and investments in therapeutic development, working in a close cooperation with the European Health Emergency Preparedness and Response Authority (HERA) preparatory action on mapping therapeutics. It will therefore ensure the coordination of all research projects on COVID-19 therapeutics, stimulating innovation and boosting therapeutic development.
- Access to and swift approval of clinical trials
- Invest €5 million under the EU4Health programme to generate better, high-quality safety data in clinical trials, which will help produce robust results in a timely manner.
- Provide EU countries with financial support of €2 million under the EU4Health 2021 work programme for expedited and coordinated assessments to facilitate approval of clinical trials.
- Explore how to support developers of therapeutics to build capacity to produce high-grade material for clinical trials.
- Scanning for candidate therapeutics
- Invest €5 million to map therapeutics and diagnostics to analyse development phases, production capacities and supply chains, including possible bottlenecks.
- Establish a broader portfolio of 10 potential COVID-19 therapeutics and identify five of the most promising ones by June 2021.
- Supply chains and delivery of medicines
- Fund a €40 million preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, which in turn will become over time an important asset for the future the European Health Emergency Preparedness and Response Authority (HERA).
- Regulatory flexibility
- Authorise at least three new therapeutics by October and possibly two more by the end of the year and develop flexible regulatory approaches to speed up the assessment of promising and safe COVID-19 therapeutics.
- Start seven rolling reviews of promising therapeutics by end-2021, subject to research and development outcomes.
- Joint procurement and financing
- Launch new contracts for the purchase of authorised therapeutics by the end of the year.
- Secure faster access to medicines with shorter administrative deadlines.
- International cooperation to make medicines available to all
- Reinforce engagement for the therapeutics pillar of the Access to COVID-19 Tools Accelerator.
- Boost ‘OPEN’ initiative for international collaboration.
The Commission will draw up a portfolio of 10 potential COVID-19 therapeutics and by June 2021, identify the five most promising ones. It will organise matchmaking events for industrial actors involved in therapeutics to ensure enough production capacity and swift manufacturing. New authorisations, rolling reviews and joint procurement contracts will be up and running before the end of the year.
The therapeutics innovation booster, matchmaking events and preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, will feed into the HERA, for which a proposal is due later in the year. The pilot project on access to health data will feed into the European Health Data Space proposal expected later this year.
Members of the College said:
Vice-President for Promoting our European Way of Life, Margaritis Schinas, said: “The situation in many intensive care units across the continent remains critical. We need to focus both on vaccines and therapeutics, as two powerful and complementary ways to combat COVID-19. But currently we have only one authorised medicine to treat COVID-19. By acting on better availability of medicines today, we are making sure patients receive the treatments they need while also preparing our future biomedical preparedness. A coordinated strategy on quick access to therapeutics will boost our strategic autonomy and contribute to a strong Health Union.”
Commissioner for Health and Food Safety, Stella Kyriakides, said: “Vaccinations save lives, but they cannot yet eradicate COVID-19. We need a strong push on treatments to limit the need for hospitalisation, speed up recovery times, and reduce mortality. Patients in Europe and across the world should have access to world-class COVID-19 medicines. This is why we have set a very clear goal: by October, we will develop and authorise three new effective COVID-19 therapeutics that can have the potential to change the course of the disease. We will do so by investing in research and innovation, the identification of new promising medicines, ramping up production capacity and supporting equitable access. Our Therapeutics Strategy is a strong European Health Union in action.”
Commissioner for Innovation, Research, Culture, Education and Youth, Mariya Gabriel, said: “By increasing vaccine availability across Europe, more and more Europeans are now protected against COVID-19. In the meantime, the development of innovative medicines to treat coronavirus patients remains a priority when it comes to saving lives. Research and innovation is the first step to finding effective and safe therapeutics, which is why we are proposing to establish a new COVID-19 ‘therapeutics innovation booster’ and will invest € 90 million in population studies and clinical trials.”
The Strategy on COVID-19 therapeutics complements the EU strategy for COVID-19 vaccines from June 2020 and builds on ongoing work by the European Medicines Agency and the Commission to support research, development, manufacturing and deployment of therapeutics.
The Strategy forms part of a strong European Health Union, using a coordinated EU approach to better protect the health of our citizens, equip the EU and its Member States to better prevent and address future pandemics, and improve the resilience of Europe’s health systems.
EU defence gets a boost as the European Defence Fund becomes a reality
Commission welcomes the adoption of the European Defence Fund (EDF), following the European Parliament’s approval. The EDF, with a budget of €7.9 billion, is the Commission’s flagship instrument to support defence cooperation in Europe. EDF will co-finance collaborative research and capability development projects amplifying national investment. It will also foster an innovative and competitive defence industrial base. In doing so, it will enhance Union’s technological sovereignty and therefore its open strategic autonomy.
Margrethe Vestager, Executive Vice-President for a Europe Fit for the Digital Age, said: “This is an important step for a stronger Europe. The Fund will play a key role to enable SMEs to participate in defence supply chains and widen cross-border industrial cooperation. Providing opportunities to companies all sizes helps achieving more innovative solutions, to foster an open internal market. So besides a stronger defence cooperation it contributes to our competitiveness.”
Thierry Breton, Commissioner for Internal Market, said: “Today marks a historic day for Europe. The idea of working together for promoting our Defence Union and for the security of EU citizens is now a tangible reality. In a global context where Europe needs to be stronger, more resilient and more autonomous in strategic areas, the European Defence Fund is a milestone and will significantly contribute to the security of EU citizens.”
A Fund to deepen EU defence industrial cooperation
Without substituting Member States’ efforts, the Fund will promote cooperation between companies of all sizes and research actors throughout the EU, in research and development of state-of-the-art and interoperable defence technology and equipment.
The Fund will support competitive and collaborative defence projects throughout the entire cycle of research and development, focusing on projects that have the potential to be game-changers for the armed forces of Member States. The Fund will foster innovation and incentivise the cross-border participation of SMEs. Projects will be defined based on defence capability priorities agreed by Member States within the framework of the Common Security and Defence Policy and particularly in the context of the Capability Development Plan. The projects will aim at contributing to the security and defence interests of the Union.
The EDF allows for the participation of European subsidiaries of third country companies and also for the cooperation with third country companies provided that their involvement ensure the security and defence interests of the EU, and meet the rigorous security conditions as set in the EDF Regulation.
A strong budget for ambitious and inclusive defence programmes
2021 constitutes the first year of the rollout of the new EDF, which will be operational for the period 2021-2027, in alignment with the Multiannual Financial Framework.
It will be endowed with a budget of €7,953,000,000 in current prices. This financial envelope will be divided into two pillars: €2,651,000,000 will be allocated to funding collaborative defence research to address emerging and future security threats and €5,302,000,000 to co-finance collaborative capability development projects.
Up to 4%-8% of the Fund budget is devoted to development or research for disruptive technologies (i.e. technologies that have the potential to create game-changing innovations). This budget represents an unprecedented opportunity to contribute to the development of a competitive and innovative European defence industry.
The complete establishment of the Fund both legally and financially will now allow the Programme Committee (PC), chaired by the Commission and composed of Member States representatives, to discuss priorities and confront topics with the aim to open calls for proposals in summer 2021. The Commission will directly manage the programme. The European Defence Agency (EDA) is invited to participate as observer and the European External Action Service (EEAS) will assist in the Committee.
The creation of a European Defence Fund was first announced in 2016. The Commission presented the first version of the European Defence Fund in June 2017, which has allowed defence cooperation at EU level to embark thanks to two pilot projects, the Preparatory Action on Defence Research (PADR) for 2017-2019 and the European Defence Industrial Development Programme (EDIDP) for 2019-2020.
The Fund is part of the priorities of the von der Leyen Commission for a ‘Stronger Europe in the World’.
A political agreement between the Member States and the European Parliament was found in December 2020 and today’s decision gives legislative effect to the EDF that will operate for the next 7 years.
Dual-use goods: what are they and why are new rules needed?
The EU is working on new export rules for so-called dual-use goods to prevent them being misused in human rights violations.
What are dual-use goods?
Dual-use products are goods designed for civilian use that in the wrong hands could be used to supress human rights or launch terrorist attacks. They can be anything from drones to chemicals.
Although these goods can improve people’s lives, they can be misused. Authoritarian regimes might use them to keep the population under control, while terrorist groups could use them to stage attacks.
Why are new rules needed?
To prevent dual-use goods being repurposed in ways that violate human rights , the EU wants to make sure strict export rules prevent them being sold to people or organisations wanting to misuse them.
The EU is currently working on an update of the existing rules to take into account recent technological developments, including new cyber surveillance tools, and beef up protection of human rights.
Eastern Balkans Economic update: Romania’s and North Macedonia’s new data for 2020
When governments around the world started reacting to the pandemic, they induced a vast and unpredictable crisis. The ensuing recession...
Political Lessons from Kerala: People’s Response to the Communist Welfare System
Amid covid-19 fears, the elections to the legislative assemblies of four Indian states- West Bengal, Tamil Nadu, Assam and Kerala,...
5th Generation Warfare: A reality or Controversy?
In the truest sense, the constant repetition of phrase ‘the 5th generation warfare’ by our military leaders in every media...
Has Modi Conceded ‘South Asia’ to the United States?
Prime Minister Narendra Modi has been pursuing an assertive and confrontational foreign policy. From carrying out ‘surgical strikes’ across the...
Angelus U30 Black Titanium: The one-of-a-kind mean machine
Offered up on the altar of the grande complication, the U30 is a piece like no other. Ultra-light and ultra-sporty,...
Conflict Affected Families in Armenia to Receive World Bank Support
A Grant Agreement for the “Support to Conflict Affected Families” project was signed today by Sylvie Bossoutrot, World Bank Country...
Russia becomes member of International Organization for Migration
After several negotiations, Russia finally becomes as a full-fledged member of the International Organization for Migration (IOM). It means that...
Energy2 days ago
Nord Stream 2: To Gain or to Refrain? Why Germany Refuses to Bend under Sanctions Pressure
Defense2 days ago
China’s quad in the making: A non-conventional approach
Americas3 days ago
Trump Lost, Biden Won. Is Joe Biden’s presidency a signal towards Obama’s America?
South Asia2 days ago
Covid19 mismanagement in India
Reports2 days ago
Clean energy demand for critical minerals set to soar as the world pursues net zero goals
Green Planet3 days ago
Climate Change Problem: an Emerging Threat to Global Security
Reports3 days ago
Global e-commerce jumps to $26.7 trillion, fuelled by COVID-19
South Asia2 days ago
Rohingya crisis: How long will Bangladesh single-handedly assume this responsibility?